Acute ocriplasmin retinopathy
- PMID: 25996428
- PMCID: PMC4457368
- DOI: 10.1097/IAE.0000000000000667
Acute ocriplasmin retinopathy
Comment on
-
Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction.Retina. 2015 Jun;35(6):1111-27. doi: 10.1097/IAE.0000000000000448. Retina. 2015. PMID: 25635577 Clinical Trial.
References
-
- Stalmans P, Benz MS, Gandorfer A, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367:606–615. - PubMed
-
- Kaiser PK, Kampik A, Kuppermann BD, et al. Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina. 2015 (CURRENT ISSUE) - PubMed
-
- Hahn P, Chung MM, Flynn HW, et al. Safety profile of ocriplasmin for vitreomacular adhesion: A comprehensive analysis of pre- and post-marketing experiences. Retina. 2015 (CURRENT ISSUE) - PubMed
-
- Quezada C, Pieramici DJ, Nasir M, et al. Outer retina reflectivity changes on SD-OCT following intravitreal ocriplasmin for vitreomacular traction and macular hole. Retina. 2015 (CURRENT ISSUE) - PubMed
-
- Reiss B, Smithen L, Mansour S. Transient vision loss following ocriplasmin injection. Retina. 2015 (CURRENT ISSUE) - PubMed
